|
Stockholders' Equity (Deficiency) (Narrative from 10Q) (Details) (USD $)
|
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Dec. 31, 2012
|
|
| Stockholders Equity Details Narrative | |||
| Offering costs | the Company raised $530,337 (net of offering costs of $184,663 and five-year warrants to purchase: (i) 100,000 common shares at $0.35 per share and (ii) 98,000 common shares at $0.50 per share.) from the sale of 20.43 Units (including 2,042,856 common shares and 1,021,432 warrants) under the offering | the Company raised $530,337 (net of offering costs of $184,663 and five-year warrants to purchase: (i) 100,000 common shares at $0.35 per share and (ii) 98,000 common shares at $0.50 per share.) from the sale of 20.43 Units (including 2,042,856 common shares and 1,021,432 warrants) under the offering | |
| Stock options granted | 646,333 | 6,777,967 | |
| Stock options granted exercise price | $ 473,200 | $ 1,895,000 | $ 0.35 |
| Stock options granted, Value | $ 0.35 | $ 1.00 | |
| Stock options vested | 56,784 | 625,350 | 910,214 |
| Fair value of stock options granted to employees | 0 | 57,750 | 1,747,007 |
| Compensation expense | 117,847 | 8,354 | 252,057 |
| Unrecognized compensation costs related to nonvested share-based compensation | 921,606 | 980,898 | |
| Unrecognized compensation costs weighted average period | 1 year 4 months 24 days | 1 year 6 months | |
| Weighted-average grant-date fair value of options granted to employees | $ 0.12 | $ 0.13 | |
| Non-employee stock options compensation expense | $ 0 | $ 57,750 | |